Catheter News and Research

RSS

In medicine, a catheter is a tube that can be inserted into a body cavity, duct, or vessel. Catheters . In most uses, a catheter is a thin, flexible tube ("soft" catheter), though in some uses, it is a larger, solid ("hard") catheter. A catheter left inside the body, either temporarily or permanently, may be referred to as an indwelling catheter. A permanently inserted catheter may be referred to as a permcath.

Boston Scientific reports positive data from PLATINUM Element Stent quantitative coronary angiography study

Boston Scientific Corporation today announced data from its PLATINUM QCA study, which is designed to evaluate the Company's PROMUS Element™ Everolimus-Eluting Platinum Chromium Coronary Stent. The results provided 30-day and nine-month clinical outcomes and nine-month quantitative coronary angiography (QCA) and intravascular ultrasound (IVUS) data supporting the safety and efficacy of the PROMUS Element Stent.

22 Sep 2010

Catheter ablation benefits atrial fibrillation patients younger than 45

Patients under age 45 had fewer major complications than older patients and comparable improvement after a medical procedure to treat irregular heartbeat, or arrhythmia, in a study reported in Circulation: Arrhythmia and Electrophysiology, an American Heart Association journal.

22 Sep 2010

Cardiac Cath Lab Director: New bimonthly journal from SAGE

Cardiac Cath Lab Director is a new bimonthly journal being launched in February 2011 by SAGE, the world's leading independent academic and professional publisher.

22 Sep 2010

PROMUS Element Stent receives expanded indications approval for high-risk diabetic and AMI patient groups

Boston Scientific Corporation today announced that its PROMUS® Element™ Everolimus-Eluting Coronary Stent System has received CE Mark approval for use in patients with diabetes and those experiencing an acute myocardial infarction (AMI), or heart attack.

21 Sep 2010

Aethlon Medical reestablishes efforts to advance Aethlon Hemopurifier

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed today that it has reestablished efforts to advance the Aethlon Hemopurifier within U.S. Government programs that support the development and purchase of treatment countermeasures against bioterror threats.

21 Sep 2010

Cook Medical sponsors sessions to reduce risk of CRBSI infections

At the 24th Annual Scientific Meeting of the Association for Vascular Access (AVA), Cook Medical continues its dedication to educating medical communities on advancements in procedures and technologies. Cook will sponsor two sessions that examine how to combine process and technology to reduce the risk of dangerous catheter-related bloodstream infections (CRBSIs).

21 Sep 2010

Cook Medical expands Spectrum Turbo-Ject line of antibiotic impregnated PICCs for CRBSIs

Responding to increased demand for technology to help prevent potentially fatal catheter-related bloodstream infections (CRBSIs), Cook Medical has expanded its Spectrum Turbo-Ject line of antibiotic impregnated peripherally inserted central venous catheters (PICCs) to treat a wider range of patient needs. For the first time, the clinical benefits of minocycline and rifampin-impregnated PICCs, a critical component in eliminating 250,000 potentially fatal CRBSIs in the U.S. annually, are now available in 3 French single and 6 French triple lumen sizes.

21 Sep 2010

3M Health Care introduces Tegaderm I.V. Advanced Securement Dressing

3M Health Care today announced the launch of 3M™ Tegaderm™ I.V. Advanced Securement Dressing for patients, a comprehensive solution with transparent, breathable film, a stabilization border and new, comfort adhesive technology. The new dressing is perceived by clinicians to reduce catheter manipulation and resist staining which could lead to less frequent dressing changes, and may provide a cost savings option for hospitals.

21 Sep 2010

Revolutions Medical files suit against cyber smear campaign

Today, Revolutions Medical Corporation filed suit in Charleston County Common Pleas Court against Philip Maurice Hicks (a.k.a. "Marty Hicks) for libel. According to the complaint, Hicks, using the alias "tazmanian353" on two Internet message boards, is alleged to be waging a cyber smear campaign in an effort to destroy RMCP and its corporate management, particularly the company's chief executive officer, Rondald Wheet.

20 Sep 2010

Vascular Solutions to distribute Shepherd Scientific's Angio Assist and Teirstein Edge products in US

Vascular Solutions, Inc. and Shepherd Scientific, Inc. today announced they have entered into a distribution agreement providing for Vascular Solutions to distribute Shepherd Scientific's Angio Assist and Teirstein Edge products in the United States. The Angio Assist is an easy-to-use docking station that facilitates the introduction of guide wires into interventional devices including catheters and atherectomy burrs.

20 Sep 2010

Boston Scientific announces acquisition of Asthmatx

Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which Boston Scientific will acquire Asthmatx, Inc., a privately held company in Sunnyvale, California. Asthmatx designs, manufactures and markets a less-invasive, catheter-based bronchial thermoplasty procedure for the treatment of severe persistent asthma in the 6 to 8 million patients 18 years and older worldwide whose asthma is not well controlled with drugs (inhaled medications).

20 Sep 2010

Stereotaxis receives 100th patent for interventional medicine

Stereotaxis, Inc. today announced that the U.S. Patent and Trademark Office granted the Company its 100th patent, a major intellectual property milestone. The 100th patent, U.S. patent No. 7,772,950, covers the "Method and Apparatus for Dynamic Magnetic Field Control Using Multiple Magnets." The 100th patent reflects Stereotaxis' ongoing commitment to innovate and protect its leading position in robotic solutions for interventional medicine.

20 Sep 2010

Aeris Therapeutics receives CE Mark approval for AeriSeal System to treat emphysema

Aeris Therapeutics, a company specializing in the development and commercialization of novel treatments for patients with emphysema and other advanced lung diseases, today announced that it has received CE Mark approval for its AeriSeal System.

20 Sep 2010

InVision-Plus connector reduces CLABSI infections: Report

The InVision-Plus needleless IV connector helped three different organizations sharply reduce and in some cases completely eliminate central line-associated bloodstream infections (CLABSI), according to three poster presentations that will be presented at AVA 2010, the annual scientific meeting of the Association for Vascular Access.

18 Sep 2010

Revolutions Medical finalizes manufacturing agreement with Medical Investment Group

Revolutions Medical Corporation today announced that the Company has finalized a manufacturing agreement with Medical Investment Group ("MIG"). Pursuant to the Manufacturing Agreement, MIG has guaranteed the production and delivery of a minimum of five million 3cc safety syringes per month for a period of five years.

17 Sep 2010

Transcatheter Technologies implants transapical aortic valve in acute porcine model

Transcatheter Technologies GmbH (TT), an innovative medical device company that is developing a second-generation transcatheter aortic valve prosthesis, announced today that its proprietary transapical aortic valve has been successfully implanted in the acute porcine model.

17 Sep 2010

Abbott to present two drug eluting stents data at TCT symposium

Abbott today announced the company's schedule of key data presentations at the Cardiovascular Research Foundation's 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Washington, D.C., to be held Sept. 21 – 25.

17 Sep 2010

NovaBay Pharmaceuticals delivers poster presentations on Aganocide compound at ICAAC Conference

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic resistant infections, delivered four poster presentations on its Aganocide compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA.

16 Sep 2010

Optical coherence tomography to penetrate intravascular ultrasound market: MRG

According to Millennium Research Group (MRG), the optical coherence tomography market will grow at an annual rate of almost 60% through 2015, spurred by physician adoption of this new technology that was launched in the US in May 2010.

16 Sep 2010

GORE C3 Delivery System enables repositioning of stent graft during procedure for AAA

W. L. Gore & Associates (Gore) today announced the first clinical uses of the GORE C3 Delivery System to deploy the GORE EXCLUDER AAA Endoprosthesis as a minimally invasive treatment for patients suffering from an abdominal aortic aneurysm (AAA).

16 Sep 2010

Catheter News and Research

Further Reading

Boston Scientific reports positive data from PLATINUM Element Stent quantitative coronary angiography study

Catheter ablation benefits atrial fibrillation patients younger than 45

Cardiac Cath Lab Director: New bimonthly journal from SAGE

PROMUS Element Stent receives expanded indications approval for high-risk diabetic and AMI patient groups

Aethlon Medical reestablishes efforts to advance Aethlon Hemopurifier

Cook Medical sponsors sessions to reduce risk of CRBSI infections

Cook Medical expands Spectrum Turbo-Ject line of antibiotic impregnated PICCs for CRBSIs

3M Health Care introduces Tegaderm I.V. Advanced Securement Dressing

Revolutions Medical files suit against cyber smear campaign

Vascular Solutions to distribute Shepherd Scientific's Angio Assist and Teirstein Edge products in US

Boston Scientific announces acquisition of Asthmatx

Stereotaxis receives 100th patent for interventional medicine

Aeris Therapeutics receives CE Mark approval for AeriSeal System to treat emphysema

InVision-Plus connector reduces CLABSI infections: Report

Revolutions Medical finalizes manufacturing agreement with Medical Investment Group

Transcatheter Technologies implants transapical aortic valve in acute porcine model

Abbott to present two drug eluting stents data at TCT symposium

NovaBay Pharmaceuticals delivers poster presentations on Aganocide compound at ICAAC Conference

Optical coherence tomography to penetrate intravascular ultrasound market: MRG

GORE C3 Delivery System enables repositioning of stent graft during procedure for AAA

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News